News

Net Loss of Zim Laboratories reported to Rs 4.02 crore in the quarter ended June 2026 as against net loss of Rs 1.87 crore during the previous quarter ended June 2025. Sales rose 31.24% to Rs 94.18 crore in the quarter ended June 2026 as against Rs 71.76 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales94.1871.76 31 OPM %2.605.94 - PBDT-0.202.43 PL PBT-5.57-2.43 -129 NP-4.02-1.87 -115 Powered by Capital Market - Live News

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 6 August 2026.

Zim Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 29 June 2026.

Zim Laboratories will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Net profit of Zim Laboratories rose 10.00% to Rs 4.40 crore in the quarter ended December 2025 as against Rs 4.00 crore during the previous quarter ended December 2024. Sales rose 12.80% to Rs 108.66 crore in the quarter ended December 2025 as against Rs 96.33 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales108.6696.33 13 OPM %11.7912.01 - PBDT11.0810.58 5 PBT6.055.70 6 NP4.404.00 10 Powered by Capital Market - Live News